RxDoctor Payments Data

John Swogger

Ophthalmology · Columbus, OHNPI 1033473483

Payments from drug & device makers

$3,307in general payments, 2019–2025

Across 81 payments — averaging $40.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • NEW World Medical,inc.$1K
  • AbbVie$1K
  • Alcon$720
  • Aerie Pharmaceuticals, Inc.$149
  • Carl Zeiss Meditec, Inc.$65
  • Sight Sciences, Inc.$25
  • plus $35 from 2 others

What the payments were for

  • Food & beverage$3,10794%
  • Education$2006%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,307 in reported general payments places this provider in the 70th percentile of 640 ophthalmology providers in Ohio.

See all ophthalmology providers in Ohio

Medicare billing

Part B allowed, 2024
$153,936
Medicare patients
400
Services billed
1,478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost239$112,186
RhopressaNetarsudil Mesylate118$50,503
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol159$32,332
RocklatanNetarsudil Mesylat/Latanoprost74$31,078
XiidraLifitegrast27$30,266
Alphagan PBrimonidine Tartrate62$23,573
RestasisCyclosporine19$22,015
Brimonidine Tartrate635$19,791
Cyclosporine26$19,512
Latanoprost1,514$18,252
SimbrinzaBrinzolamide/Brimonidine Tart43$18,106
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat851$17,798
CombiganBrimonidine Tartrate/Timolol28$12,957
Prednisolone Acetate241$10,665
ZioptanTafluprost/Pf13$7,248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan, Alphagan P, Restasis, Combigan$1,133$170,731348 claims
Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan$149$81,581192 claims
AlconSimbrinza$720$18,10643 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 640 ophthalmology providers in Ohio.

Other ophthalmology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →